Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Timothy Anthony Yap

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2154-3309; OpenAlex author ID A5068368047. Sources: ClinicalTrials.gov.

Their work

Papers
3 (first author 0, last author 1)
Trials
3 (principal investigator on 3)
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2017: 1 trial · 2018: none · 2019: 1 paper · 2020: 1 trial · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 trial

Papers 3

  1. Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Tri… Co-author DOI 10.1007/s12029-023-00930-7↗
  2. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41467-021-24798-y↗
  3. PARP inhibition - opportunities in pancreatic cancer. Last author DOI 10.1038/s41571-019-0257-6↗

Trials 3

  1. Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid… Principal investigator NCT06130254↗
  2. Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies Principal investigator NCT04644068↗
  3. IACS-010759 in Advanced Cancers Principal investigator NCT03291938↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shubham Pant · 2 shared papers, 2019–2023 · strength 0.33
  2. Anirban Maitra · 2 shared papers, 2019–2021 · strength 0.24
  3. Funda Meric-Bernstam · 1 shared paper, 2023 · strength 0.17
  4. Robert A. Wolff · 1 shared paper, 2023 · strength 0.17
  5. Jane Elizabeth Rogers · 1 shared paper, 2023 · strength 0.17
  6. Rishi Surana · 1 shared paper, 2023 · strength 0.17
  7. Jordi Ahnert Rodon · 1 shared paper, 2023 · strength 0.17
  8. Brandon George Smaglo · 1 shared paper, 2023 · strength 0.17
  9. Vivek Subbiah · 1 shared paper, 2023 · strength 0.17
  10. David S. Hong · 1 shared paper, 2023 · strength 0.17
  11. Aung Naing · 1 shared paper, 2023 · strength 0.17
  12. Andrea Viale · 1 shared paper, 2021 · strength 0.08
  13. Alessandro Carugo · 1 shared paper, 2021 · strength 0.08
  14. Virginia Giuliani · 1 shared paper, 2021 · strength 0.08
  15. Timothy Paul Heffernan · 1 shared paper, 2021 · strength 0.08
  16. Giannicola Genovese · 1 shared paper, 2021 · strength 0.08
  17. Johnathon Lynn Rose · 1 shared paper, 2021 · strength 0.08
  18. Hideo Tomihara · 1 shared paper, 2021 · strength 0.08
  19. Haoqiang Ying · 1 shared paper, 2021 · strength 0.08
  20. Jason B. Fleming · 1 shared paper, 2021 · strength 0.08
  21. Michael P. Kim · 1 shared paper, 2021 · strength 0.08
  22. Giulio Francesco Draetta · 1 shared paper, 2021 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.